CareAll: Hidden Control, Inflated Severity, and a Second Settlement

Whistleblower Justice Network

The CareAll home health fraud settlements were separate agreements to pay $9.375 million over allegedly concealed management-company relationships and $25 million over alleged upcoding and medically unnecessary care. For someone inside a home health agency, the distinction matters: one case followed who really controlled the business, the other followed what the business said about its patients.

The Justice Department announced the cost-report settlement on August 10, 2012 and the clinical-billing settlement on November 12, 2014. The earlier agreement required payment to the federal government. The later agreement required payment to the United States and Tennessee over Medicare and Medicaid billings. The department described Nashville-based CareAll as one of Tennessee’s largest home health providers.

The Cost Reports Hid Who Controlled the Agencies, the Government Alleged

The earlier case concerned eight Medicare cost reports for fiscal years 1999, 2000 and 2001. The government alleged that the reports concealed the relationship between the home health agencies and their management company. The government alleged that disclosing that relationship would have lowered Medicare’s reimbursement for the management services. By the announcement, the agencies operated under the CareAll name.

The alleged arrangement put a friend of the management company’s owner forward as the agencies’ owner. According to the government, that friend was a figurehead. The government alleged that the management company’s owner helped arrange the agencies’ purchase, that his companies lent them millions of dollars, and that the management company transferred millions of dollars and controlled daily operations. The government also alleged that the management company’s owner profited from the arrangement and paid the figurehead for participating.

Those details explain why the ownership question reached the Medicare bill. The government alleged that management services were being reimbursed without disclosing the control behind them. We see the absurdity in that account: the business allegedly running the agencies every day disappeared from the relationship reported for reimbursement. Separate names on the paperwork, shared control over the work.

For an agency finance or operations employee, the revealing records would connect the ownership account to the loans, transfers, management decisions and cost reports. The government’s theory followed how the agencies were bought, funded and run. An organization chart was only the beginning of that story.

Why the Cost-Report Years Matter

Medicare was changing how it paid home health agencies during the years covered by the allegations. The Medicare Payment Advisory Commission’s June 1999 payment analysis describes the interim system’s continued use of cost reimbursement, subject to agency payment limits. Effective October 1, 2000, Medicare replaced retrospective cost settlement with payment for 60-day episodes, adjusted for patients’ care needs and local wages.

Those cost-report years crossed a change in how Medicare paid agencies. Our review connects the allegedly hidden control and reported expense to the payment rules for the period being billed.

The United States brought this case. The Justice Department identified its Civil Division, the U.S. Attorney’s Office for the Middle District of Tennessee and the Department of Health and Human Services Office of Inspector General as conducting the investigation.

The Later Case Put Patient Severity and Eligibility at the Center

The later settlement resolved allegations that, between 2006 and 2013, CareAll overstated the severity of patients’ conditions to increase billings and billed for medically unnecessary services provided to patients who were not homebound. The alleged inflation put taxpayers’ money into agency revenue instead of the home health care those programs were meant to fund.

Severity and eligibility answer different payment questions. In the government’s account, overstating severity increased the bill. Billing unnecessary care or care for patients who were not homebound reached whether those services qualified for payment at all.

For a severity allegation, the comparison runs from the clinician’s findings through the assessment, care plan and visit records to the claim. Those records let us see whether the condition described for payment matches the care the patient needed and received.

The Centers for Medicare & Medicaid Services’ home health benefit manual explains the homebound test in terms of the patient’s ability to leave home and the considerable effort involved. It also requires clinical support for that account. For an insider, a stock description becomes revealing when it conflicts with what the clinician actually observed.

Medicare’s initial qualifying skilled need is intermittent skilled nursing, physical therapy or speech-language pathology. Continued occupational therapy can sustain eligibility after an initial qualifying service ends. A nurse, therapist or billing employee may know where the care required, the services ordered and the bill stopped matching.

What Clinical Payment Pressure Looks Like in Other Cases

Other home health complaints give concrete examples of the pressure an insider might recognize. In the whistleblower complaint against Amedisys, former employees allegedly reported that corporate management wanted a 100% recertification rate after the first 60-day episode, whether continued care was reasonable or necessary.

The complaint against Carter Healthcare alleged an 18-visit target per certification period, regardless of medical necessity and sometimes before an initial examination. It also quoted an internal email directing what should remain in a clinical note:

Going forward, if it is not significant information to support the medical necessity of the patient, please omit that information from your SOAP note.

Internal email quoted in the whistleblower’s complaint, United States ex rel. Mahaffey v. Carter Healthcare, paragraph 197

The alleged instruction worked backward from the billing justification to the clinical record. These separate complaints show why we care about the instructions behind a chart: a recertification target, a visit quota or an instruction to omit information can explain how the final record came to tell its story.

A Second Settlement Brought Stronger Oversight

CareAll agreed to a corporate integrity agreement with the health department’s inspector general in the earlier settlement. The later resolution included an enhanced and extended agreement intended to prevent future fraud and compliance failures.

A first settlement, then stronger oversight. We see the problem: CareAll had already agreed to oversight while the period covered by the later billing allegations was still running.

A 2024 Georgetown Environmental Law Review paper about whistleblower enforcement reports an estimate from earlier healthcare studies:

Researchers examining the healthcare sector have estimated that each dollar paid to settle an FCA lawsuit deters ten times as much additional fraud.

False Claims, Real Climate Harm: How Whistleblowers Can Fight Fraud in the Renewable-Energy, REC, and Carbon-Offset Markets, Georgetown Environmental Law Review, 2024

The studies concern health care enforcement more broadly. Their point is that changing future billing behavior can matter well beyond the money recovered in a particular case. CareAll’s enhanced agreement put future compliance expressly alongside the settlement payment.

What Evidence Is Needed to Prove Fraud?

For the practices alleged in the CareAll cases, the evidence connects a false representation to the payment it affected and the people who controlled that representation. The cost-report story follows management control and money transfers. The clinical story follows patient condition, skilled need, homebound support and the bill.

An insider’s account helps explain why the records differ. In a cost-report matter, that can mean knowing who directed the agencies despite the ownership shown on paper. In a clinical-billing matter, it can mean knowing who instructed staff to change an assessment or justify continuing care. Connecting those decisions to particular claims is the work we do with you.

The payment record matters too. CMS’s claims-processing manual describes the path from claim information to payment. The remittance shows what Medicare actually paid after adjustments. Bring us the part of that story you know; our whistleblower experts work with you to connect it to the payment.

How Much Can a Medicare Fraud Whistleblower Receive?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In CareAll’s later case, the Justice Department announced that the whistleblower would receive more than $3.9 million as a share of the recovery.

That case began as a whistleblower’s qui tam action. The department credited the settlement to a coordinated effort by its Civil Division, the U.S. Attorney’s Office for the Middle District of Tennessee, the health department’s inspector general and the Tennessee Bureau of Investigation.

You Know the Agency Behind the Bill

If you know who really runs an agency or why its patient records differ from the care you saw, speak to our whistleblower experts about the records behind the bill. We build the case with you and bring in home health fraud whistleblower lawyers who understand cost reports, clinical eligibility and Medicare and Medicaid billing. We stay beside you, using your knowledge of the business to build your strongest home health whistleblower case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365